Skip to main content
OpenTrials

Clinical trial condition

Alzheimer Disease

Explore clinical trials studying Alzheimer Disease. Study availability and eligibility vary by location and protocol.

1,340 public trials 298 recruiting studies
Refine in advanced search Browse all conditions

Alzheimer Disease trial results

Completed

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

NCT00285077

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Sanofi-Aventis Administrative Office Laval, Canada
  • Sanofi-Aventis Administrative Office Horslholm, Denmark
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Paris, France
View Trial Details
Completed

Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

NCT00380302

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Paris, France
  • Sanofi-Aventis Administrative Office Milan, Italy
  • Sanofi-Aventis Administrative Office Gouda, Netherlands
View Trial Details
Completed

A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.

NCT00765115

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • For additional information regarding investigtive sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician St Louis, Missouri, United States
View Trial Details
Completed

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00104013

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Neurological Physicians of Arizona, Inc. Mesa, Arizona, United States
  • Pivotal Research Centers Mesa, Arizona, United States
  • Pivotal Research Centers Peoria, Arizona, United States
  • Northwest NeuroSpecialists Tucson, Arizona, United States
View all 41 locations
View Trial Details
Completed

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00103649

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • UAB Memory Disorders Clinic Birmingham, Alabama, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • PsyPharma Clinical Research, Inc. Phoenix, Arizona, United States
  • Radiant Research Scottsdale, Arizona, United States
View all 121 locations
View Trial Details

Related conditions